BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3454379)

  • 1. HLA-DR, DRw52.53, and DQ homozygosity in patients with neural tube defects.
    Wong AC; Aoki K; Yagami Y; Akaza T; Takeuchi S; Matsunaga T
    Jinrui Idengaku Zasshi; 1987 Dec; 32(4):319-27. PubMed ID: 3454379
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
    Eiermann TH; Martin A; Wölpl A; Goldmann SF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens.
    Awad J; Navarrete C; Sachs JA; Festenstein H; Cassell PG; Niven MJ; Hitman G
    Immunogenetics; 1988; 27(1):73-6. PubMed ID: 2890578
    [No Abstract]   [Full Text] [Related]  

  • 4. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the HLA-D region by pulsed-field gel electrophoresis: size variation in the DQ-DR interval.
    Inoko H; Ando A; Tsuji K
    Tokai J Exp Clin Med; 1990 May; 15(2-3):253-60. PubMed ID: 2130532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of specific HLA-DQ alpha allospecificities by genomic, biochemical, and serologic analysis.
    Amar A; Radka SF; Holbeck SL; Kim SJ; Nepom BS; Nelson K; Nepom GT
    J Immunol; 1987 Jun; 138(11):3986-90. PubMed ID: 2438332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel.
    Awad J; Navarrete C; Festenstein H
    Tissue Antigens; 1987 Jan; 29(1):55-9. PubMed ID: 3473746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inheritance of insulin-dependent diabetes.
    Klitz W
    Nature; 1988 Jun; 333(6172):402-3. PubMed ID: 3374583
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.
    Bidwell J
    Immunol Today; 1988 Jan; 9(1):18-23. PubMed ID: 2908266
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA and celiac disease in Argentina: involvement of the DQ subregion.
    Palavecino EA; Mota AH; Awad J; Derosa S; Herrera M; Chertkoff L; Satz L; Fainboim L
    Dis Markers; 1990; 8(1):5-10. PubMed ID: 2311351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with psoriasis vulgaris.
    Olerup O; Wallin J; Carlsson B; Marcusson J; Emtestam L; Björnelius E; Möller E
    Tissue Antigens; 1987 Sep; 30(3):139-42. PubMed ID: 2892283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Barker et al. (2008) Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: Diabetes 57:3152-3155, 2008.
    Romanos J; Wijmenga C
    Diabetes; 2009 Jan; 58(1):e1; author reply e2. PubMed ID: 19114716
    [No Abstract]   [Full Text] [Related]  

  • 15. A sex-specific difference in homozygosity for HLA-DR53 in newborns.
    Sunguroğlu A; Güç D; Sipahi TU; Dorak MT
    Turk J Pediatr; 1998; 40(2):211-6. PubMed ID: 9677726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction fragment length polymorphism in Felty's syndrome.
    Sansom DM; Bidwell JL; Klouda PT; Maddison PJ
    Dis Markers; 1986 Jun; 4(1-2):185-9. PubMed ID: 2898315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombination sites in the HLA class II region are haplotype dependent.
    Gregersen PK; Kao H; Nunez-Roldan A; Hurley CK; Karr RW; Silver J
    J Immunol; 1988 Aug; 141(4):1365-8. PubMed ID: 3135331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines.
    Fernandez N; Labeta M; Kurpisz M; Solana R; Festenstein H
    Dis Markers; 1986 Jun; 4(1-2):191-8. PubMed ID: 3502560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybridization analysis reveals novel DQw3 alpha-beta associations suggesting a recombination point between DQ alpha and DQ beta on the HLA-DR4 haplotype.
    Bushell A; Wood KJ; Morris PJ
    Immunogenetics; 1988; 27(6):456-9. PubMed ID: 3259544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anencephalus immunogenetic factor].
    Fujisawa S; Aoki K; Yagami Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):470-6. PubMed ID: 3457878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.